divalproex sodium delayed-release capsules

divalproex sodium delayed-release capsules
SPL v9
SPL
SPL Set ID b0f33792-dd96-40cc-a28e-acdcdca2f4b8
Route
oral
Published
Effective Date 2023-09-21
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
valproic acid (125 mg)
Inactive Ingredients
alcohol ammonia butyl alcohol cellulose, microcrystalline fd&c blue no. 1 ferrosoferric oxide gelatin hypromelloses isopropyl alcohol methacrylic acid potassium hydroxide propylene glycol shellac silicon dioxide sodium lauryl sulfate talc titanium dioxide triethyl citrate water

Identifiers & Packaging

Pill Appearance
Imprint: ZA66;125mg Shape: capsule Color: blue Color: white Size: 22 mm Score: 1
Marketing Status
anda active Since 2009-01-27

Description

NDC 65841-639-01 in bottle of 100 Capsules Divalproex sodium delayed-release capsules, USP (sprinkle) Rx only 100 capsules


Medication Information

Description

NDC 65841-639-01 in bottle of 100 Capsules Divalproex sodium delayed-release capsules, USP (sprinkle) Rx only 100 capsules

Package Label.principal Display Panel

NDC 65841-639-01 in bottle of 100 Capsules

Divalproex sodium delayed-release capsules, USP (sprinkle)

Rx only

100 capsules


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 65841-639-01 in bottle of 100 Capsules

Divalproex sodium delayed-release capsules, USP (sprinkle)

Rx only

100 capsules


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)